From breath to block: Disseminated invasive aspergillosis presenting with pulmonary, ocular, myocardial and cerebral involvement, and high-grade atrioventricular block during acalabrutinib therapy for chronic lymphocytic leukaemia. [PDF]
Young AB, Birkby S, Knight D, Leslie S.
europepmc +1 more source
Pirtobrutinib Monotherapy for First-Line Chronic Lymphocytic Leukemia: A Non-Anchored Indirect Comparison Using Reconstructed Patient-Level Data. [PDF]
Messori A +3 more
europepmc +1 more source
Comparative atrial fibrillation risk across Bruton's tyrosine kinase inhibitors in B-cell malignancies: A nationwide population-based study. [PDF]
Zelmat Y +5 more
europepmc +1 more source
Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up. [PDF]
Owen RG +18 more
europepmc +1 more source
Acalabrutinib Versus Venetoclax Plus Obinutuzumab in Treatment-Naive Chronic Lymphocytic Leukemia: A Real-World Propensity Score-Matched Study. [PDF]
Liao PW, Ko BS, Su YC, Chao WT, Teng CJ.
europepmc +1 more source
Absence of a prolonged macrophage and B cell response inhibits heart regeneration in the Mexican cavefish. [PDF]
Sengul E +14 more
europepmc +1 more source
Efficacy and Safety of Bruton Tyrosine Kinase Inhibitors in Waldenström Macroglobulinemia: A Single-Center Retrospective Analysis. [PDF]
Singh M +20 more
europepmc +1 more source

